Background With the application of early reperfusion by thrombolysis after acute MI, the importance of nontransmural infarction is increasing. We evaluated 1 the changes of LV dimension, LV fibrosis and transforming growth factor-1 TGF-1 mRNA expression in a rat model of nontransmural infarction and 2 effects of angiotensin converting enzyme inhibitor ACEI and angiotensin II receptor blocker ATRB treatment after nontransmural infarction. Method and Results Female Sprague-Dawley rats were subjected to 45 minutes of coronary occlusion followed by reperfusion, and at 5 days after the operation, animals were randomized to untreated MIvehicle, n 19 , captopril-treated MI-captopril, n 15 and losartan-treated MI-losartan, n 14 groups. LV dimension, measured by transthoracic echocardiography, was significantly increased at 26 days after MI, and both captopril and losartan treatment inhibited LV cavity dilatation LV end-diastolic dimension mm MI-vehicle, MI-captopril, MI-losartan 8.6 0.2, 7.8 0.2, 8.0 0.2, p 0.05 vs. MI-vehicle each . Interstitial fibrosis was reduced with both captopril and losartan treatment p 0.05 vs. MI-vehicle . TGF-1 mRNA increased 2.6 fold at 10 days p 0.05 vs. pre-MI , and normalized at 26 days after nontransmural MI. Captopril and losartan treatment blocked the induction of TGF-1 expression after nontransmural MI p NS vs. pre-MI . Conclusion After large nontransmural MI, ACEI and ATRB treatments attenuate LV remodeling and decrease interstitial fibrosis, at least partly by blocking the acute induction of TGF-1 mRNA expression. Korean Circulation J 1998 ; 28 9 : 1590-1599

